New approaches to anticancer drug design based on the inhibition of farnesyltransferase
Open Access
- 31 January 1998
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 3 (1) , 26-33
- https://doi.org/10.1016/s1359-6446(97)01122-7
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- On the Stereochemical Course of Human Protein-Farnesyl TransferaseJournal of the American Chemical Society, 1996
- Local constrained shifty pseudopeptides inhibitors of rasfarnesyl transferaseBioorganic & Medicinal Chemistry Letters, 1995
- Constrained analogs of KCVFM with improved inhibitory properties against farnesyl transferaseBioorganic & Medicinal Chemistry Letters, 1995
- Polylysine and CVIM Sequences of K-RasB Dictate Specificity of Prenylation and Confer Resistance to Benzodiazepine Peptidomimetic in VitroJournal of Biological Chemistry, 1995
- Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeuticCell, 1994
- Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformationNature, 1993
- How receptors turn Ras onNature, 1993
- Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathwaysCell, 1992
- All ras proteins are polyisoprenylated but only some are palmitoylatedCell, 1989
- ras GENESAnnual Review of Biochemistry, 1987